Victory Capital Management
BNTX icon

Victory Capital Management’s BioNTech BNTX Stock Holding History

Victory Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.2M Buy
539,787
+62,864
+13% +$5.92M 0.03% 580
2026
Q1 		$42.4M Buy
476,923
+76,330
+19% +$7.84M 0.03% 598
2025
Q4 		$38.1M Sell
400,593
-13,092
-3% -$1.32M 0.02% 648
2025
Q3 		$37.5M Buy
413,685
+203,700
+97% +$21.8M 0.02% 675
2025
Q2 		$22.6M Buy
+209,985
New +$21.2M 0.01% 833
2024
Q4 		– Sell
-2,907
Closed -$345K – 2480
2024
Q3 		$345K Buy
+2,907
New +$267K ﹤0.01% 2101
2023
Q1 		– Sell
-10,235
Closed -$1.54M – 2600
2022
Q4 		$1.54M Buy
10,235
+708
+7% +$109K ﹤0.01% 1532
2022
Q3 		$1.28M Buy
+9,527
New +$1.46M ﹤0.01% 1620
2022
Q2 		– Sell
-10,460
Closed -$1.45M – 2701
2022
Q1 		$1.45M Sell
10,460
-1,200
-10% -$202K ﹤0.01% 1623
2021
Q4 		$3.01M Buy
11,660
+1,092
+10% +$299K ﹤0.01% 1439
2021
Q3 		$2.88M Buy
+10,568
New +$3.36M ﹤0.01% 1474

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Victory Capital Management's BNTX Position: Q2 2026 in Review

Victory Capital Management increased its BioNTech (BNTX) stake by 13% in Q2 2026, buying an estimated $5.92M and bringing the position to 539,787 shares worth $50.2M. The position accounts for 0.03% of the portfolio, ranked #580.

Victory Capital Management first reported a position in BNTX in Q3 2021 and has held it in 11 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Victory Capital Management held 539,787 shares of BioNTech worth $50.2M as of Q2 2026.
  • Victory Capital Management bought 62,864 BioNTech shares in Q2 2026, an estimated $5.92M.
  • BioNTech made up 0.03% of Victory Capital Management's portfolio in Q2 2026, its #580 holding.
  • Victory Capital Management first reported a position in BioNTech in Q3 2021 and has held it in 11 quarters since.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.